These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 12960127)
1. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127 [TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [TBL] [Abstract][Full Text] [Related]
3. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245 [TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671 [TBL] [Abstract][Full Text] [Related]
5. p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis. Matsuda Y; Ichida T Med Mol Morphol; 2006 Dec; 39(4):169-75. PubMed ID: 17187177 [TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma. Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070 [TBL] [Abstract][Full Text] [Related]
7. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Qin LF; Ng IO Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219 [TBL] [Abstract][Full Text] [Related]
8. Expression and activity of cell cycle-regulatory proteins in normal and transformed corneal endothelial cells. Schönthal AH; Hwang JJ; Stevenson D; Trousdale MD Exp Eye Res; 1999 May; 68(5):531-9. PubMed ID: 10328966 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. Matsuda Y World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. Wong SC; Chan JK; Lee KC; Hsiao WL J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259 [TBL] [Abstract][Full Text] [Related]
12. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance. Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709 [TBL] [Abstract][Full Text] [Related]
13. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia. Said TK; Moraes RC; Singh U; Kittrell FS; Medina D Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803 [TBL] [Abstract][Full Text] [Related]
15. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340 [TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562 [TBL] [Abstract][Full Text] [Related]
18. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477 [TBL] [Abstract][Full Text] [Related]
19. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Migita T; Oda Y; Naito S; Tsuneyoshi M Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465 [TBL] [Abstract][Full Text] [Related]
20. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]